Figures
Abstract
A direct and continuous approach to determine simultaneously protein and phosphate concentrations in cells and kinetics of phosphate release from physiological substrates by cells without any labeling has been developed. Among the enzymes having a phosphatase activity, tissue non-specific alkaline phosphatase (TNAP) performs indispensable, multiple functions in humans. It is expressed in numerous tissues with high levels detected in bones, liver and neurons. It is absolutely required for bone mineralization and also necessary for neurotransmitter synthesis. We provided the proof of concept that infrared spectroscopy is a reliable assay to determine a phosphatase activity in the osteoblasts. For the first time, an overall specific phosphatase activity in cells was determined in a single step by measuring simultaneously protein and substrate concentrations. We found specific activities in osteoblast like cells amounting to 116 ± 13 nmol min-1 mg-1 for PPi, to 56 ± 11 nmol min-1 mg-1 for AMP, to 79 ± 23 nmol min-1 mg-1 for beta-glycerophosphate and to 73 ± 15 nmol min-1 mg-1 for 1-alpha-D glucose phosphate. The assay was also effective to monitor phosphatase activity in primary osteoblasts and in matrix vesicles. The use of levamisole – a TNAP inhibitor- served to demonstrate that a part of the phosphatase activity originated from this enzyme. An IC50 value of 1.16 ± 0.03 mM was obtained for the inhibition of phosphatase activity of levamisole in osteoblast like cells. The infrared assay could be extended to determine any type of phosphatase activity in other cells. It may serve as a metabolomic tool to monitor an overall phosphatase activity including acid phosphatases or other related enzymes.
Citation: Ren Z, Do LD, Bechkoff G, Mebarek S, Keloglu N, Ahamada S, et al. (2015) Direct Determination of Phosphatase Activity from Physiological Substrates in Cells. PLoS ONE 10(3): e0120087. https://doi.org/10.1371/journal.pone.0120087
Academic Editor: Elena Aikawa, Brigham and Women's Hospital, Harvard Medical School, UNITED STATES
Received: September 26, 2014; Accepted: January 19, 2015; Published: March 18, 2015
Copyright: © 2015 Ren et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper.
Funding: Mr. Zhongyuan Ren received a PhD scholarship from the China Scholarship Council http://en.csc.edu.cn. Mr. Le Duy Do is a recipient of the fellowship from the International PhD program in Neurobiology (project No 06 - collaborative PhD project between the Nencki Institute of Experimental Biology and Universite Lyon 1) http://neurophd.nencki.gov.pl. This research was supported by the following: the French Agency for the promotion of higher education and international mobility (Campus France) (Grant: Polonium N° 27727TA), http://www.campusfrance.org/fr/; CNRS International project of scientific cooperation (PICS) (Grant N° 5096) http://www.cnrs.fr/derci/spip.php?article51; Polish Ministry of Science and Higher Education (Grant N° N401 140639) http://www.nauka.gov.pl/en/ and European Union Capacities Programme (Research potential) (Grant N° EU FP7 Project Bio-imaging in research Innovation and education, GA No. 264173) http://bioimagine.nencki.gov.pl/en/?p=glowna&lng=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Among the enzymes having a phosphatase activity and releasing Pi, tissue non-specific alkaline phosphatase (TNAP) performs indispensable, multisystemic functions in humans [1]. It is expressed with high levels in bones, liver and neurons. It is absolutely required for bone mineralization and also necessary for neurotransmitter synthesis. So far there is no direct methodological approach to determine phosphate in the living cells without the need of labelling. Most standard methods for measuring inorganic phosphate or pyrophosphate are based on coupled enzyme assays, colorimetric methods, conductance, or radioactivity labeling which do not allow one-step determination in the cells. Protein determination and activity measurements must be performed separately. For example, the screening of TNAP inhibitors relied on the determination of the recombinant TNAP activity at alkaline pH using para-nitrophenylphosphate (pNPP), which is not a physiological substrate. A 1,000-fold more sensitive and 10-fold faster than the pNPP assay has been developed with pNPP dioxetane-based substrate [2–3]. However, TNAP inhibitors selected by using non physiological substrates may act differently on the living cells. Therefore, there is a strong demand for flexible and fast strategies to select inhibitors with improved prospects for clinical success [4]. Infrared (IR) spectroscopy [5] has been employed to identify specific finger-like signatures in microbial cells [6–10] in tumour cells [11–16] or in tissues [17–19] giving information of overall structural and biochemical cell composition or changes induced by anti-tumour drugs in cells [20–28]. Alkaline phosphatase activity in sera [29] has been determined by IR, suggesting the possibility of using IR for quantitative determination of an enzymatic activity in whole cells. Here, we report a continuous IR assay to determine phosphatase activity in osteoblasts and in matrix vesicles released by chondrocytes, characterized by high TNAP activity. We provided the proof of concept that infrared spectroscopy is a reliable assay to determine a phosphatase activity in the osteoblasts. For the first time, an overall specific phosphatase activity in a single step by measuring simultaneously protein and substrate concentrations was determined.
Materials and Methods
Isolation of matrix vesicles
Matrix vesicles (MVs) were prepared according to Wuthier’s method [30]. Femurs from twenty 17-day-chicken embryos were taken. Slices (1–3 mm thick) of growth plates and ephyseal cartilage were cut. They were washed five times in synthetic cartilage lymph (SCL) buffer containing 1.42 mM NaH2PO4·H2O, 1.83 mM NaHCO3, 12.7 mM KCl, 0.57 mM MgCl2, 5.55 mM D-glucose, 63.5 mM sucrose, 16.5 mM TES, 100 mM NaCl, 0.57 mM Na2SO4, pH 7.4. The slices were incubated at 37°C for 180 min by mixing continuously in SCL buffer containing 200–500 units g-1 tissue of type I collagenase from Clostridium histolyticum (Sigma) and 1 mM CaCl2·H2O. Then, it was filtered through a nylon filter. The filtrate was centrifuged at 600 g for 15 min at 4°C. After the first centrifugation the debris were discarded and the supernatant was centrifuged at 20 000 g for 20 min at 4°C. A second centrifugation at 80 000g for 60 min at 4°C was then performed. The supernatant was discarded and the pellet was gently washed with 1 mL Tris HCL (100 mM, pH 8.0) containing 5 μM ZnCl2 and 5 mM MgCl2. Washing medium was discarded and the intact pellet (around 0.05 mL) was suspended in 0–2 mL Tris HCL (100 mM, pH 8.0) containing 5 μM ZnCl2 and 5 mM MgCl2 (called throughout buffer A). The protein concentration in MVs was determined by Bradford [31] was in the range of 0.2 to 8 mg MV protein mL-1. MVs were freshly prepared for the IR measurements.
Saos-2 Cells
Human osteosarcoma Saos-2 cells (ATCC HTB-85) were cultured in DMEM medium supplemented with 100 U mL-1 penicillin, 100 g mL-1 streptomycin (both from Sigma) and 10% FBS (v:v, Gibco). Stimulation of Saos-2 cells was induced by culturing the confluent cells in growth medium supplemented with 50 μg mL-1 ascorbic acid (AA) (Sigma) and 7.5 mM β-glycerophosphate (Sigma). After a six-day incubation, Saos-2 cells were detached with trypsin (Sigma) and 1 mM CaCl2·H2O. The cells were washed with 1 mL buffer A. After centrifugation, the supernatant was discarded. The washing and centrifugation procedures were repeated three times so that the DMEM buffer and trypsin were completely removed. An aliquot of 0.5 to 1.5 mg of freshly prepared Saos-2 cells as determined by weighting was taken and kept in Eppendorf tubes for the IR measurements. The cells were freshly prepared for IR measurements.
Primary cell cultures from mice
All experiments were carried out according to the guidelines laid down by the French Ministère de l’Agriculture (n° 87–848) and the E.U. Council Directive for the Care and Use of Laboratory Animals of November 24th, 1986 (86/609/EEC). Animal experiments were performed under the authorization n°69–266–0501 (INSA-Lyon, DDPP-SV, Direction Départementale de la Protection des Populations—Services Vétérinaires du Rhône), according to the guidelines laid down by the French Ministère de l’Agriculture (n° 87–848) and the E.U. Council Directive for the Care and Use of Laboratory Animals of November 24th, 1986 (86/609/EEC). MLC (n°692661241), AG (n°69266332) and COS (n°69266257) hold special licenses to experiment on living vertebrates issued by the French Ministry of Agriculture and Veterinary Service Department. The experiments were realized on euthanized animals by dislocation of cervical vertebra, which didn’t require surgery and were not painful. This study was specifically approved by the Committee on the Ethics of Animal Experiments of the INSA of Lyon CETIL (permit Number: 012012). The preparation of primary cells were performed at INSA of Lyon, IMBL Building, 69100 Villeurbanne, France. Primary osteoblast cells were enzymatically isolated from calvaria (frontal and parietal bones) of 5–6 days old mice (C57BL/6J strain). Calvaria were dissected aseptically and cells were isolated using sequential digestion at 37°C with trypsin/EDTA 0.05% during 20 min and then with liberase 0.8 U mL-1 during 20 min. The first two digests were discarded, and cells obtained after two 45 min digestions with liberase 0.8 U mL-1 were collected, pooled and then filtered through a 100 μm cell strainer. The cells were plated at a density of 1 × 105 cells per well in 22.1 mm culture dish in DMEM containing 15% FBS (v:v, Gibco), 100 U mL-1 penicillin and 100 μg mL-1 streptomycin (both from Sigma) and switched 24h later to growth medium i.e., DMEM containing 10% FBS (v:v, Gibco), supplemented with 50 μg mL-1 ascorbic acid (Sigma). After six days of culture, the medium was further supplemented with 7.5 mM β-glycerophosphate (Sigma) and 50 μg mL-1 ascorbic acid during one week. Primary cultures were used without passage. Cultures were maintained in a humidified atmosphere consisting of 95% air/5% CO2 at 37°C. After a six-day incubation, primary cells were detached with trypsin (Sigma) and 1 mM CaCl2·H2O. The cells were washed with 1 mL buffer A or with 1 mL DMEM buffer. After centrifugation, the supernatant was discarded. The washing and centrifugation procedures were repeated three times so that trypsin was completely removed. An aliquot of 0.5 to 1.5 mg of freshly prepared osteoblasts as determined by weighting was taken and kept in Eppendorf tubes for the IR measurements. The cells were freshly prepared for IR measurements.
Infrared spectra
To start the reaction, an aliquot of either MV (0.5 to 8 mg protein mL-1), Saos-2 cells (6 to 28 mg protein mL-1) or primary osteoblast (20 to 45 mg protein mL-1) was taken and mixed with the reaction medium containing 40–80 mM final PPi or one of other substrates (AMP, ADP, ATP, UTP, α-D-glucose 1-phosphate (G-1P), β-glycerophosphate (β-GP) and para-nitrophenylphosphate (pNPP)) in buffer A. Final protein concentrations in MVs or in cells were determined directly by measuring the intensity of the amide-II band at 1550-cm-1 with the concentration absorption coefficient ε = 3.6 mg-1mL cm-1. ε was determined by using bovine serum albumin as a protein Five μL of the reaction mixture containing either MVs or Saos-2 cells or primary osteoblast cells were taken and deposited between two BaF2 windows of a demountable thermostated cell (model Harrick) separated with a 12 μm (for IR spectra of substrates) or 6 μm (for IR spectra of cells with substrates) Teflon spacer. IR data were acquired with a Thermo Scientific Nicolet iS10 spectrometer equipped with a DTGS detector. The IR spectra were recorded with a thermostated IR cell kept at 37°C with 128 interferograms at 4 cm–1 resolution each and then Fourier transformed. During data acquisition, the spectrometer was continuously purged with dry filtered air (Balston regenerating desiccant dryer, model 75–45 12 VDC). At least three independent measurements have been performed to obtain the kinetics parameters. To minimize cell to cell variation, affecting TNAP activity, the same cell preparations were used to compare with the controls. For the determination of IC50 of levamisole, relative activities were measured to take into account of the cell to cell variations.
Results and Discussion
IR spectra of phosphatase substrates
IR spectra of phosphatase substrates such as AMP, ADP, ATP, UTP, α-D-glucose 1-phosphate (G-1P), β-glycerophosphate (β-GP), pNPP and PPi in aqueous Tris-HCl buffer (pH 8) containing 5 mM MgCl2 and 5 μM ZnCl2 (buffer A) present sufficient differences in band shapes and positions as compared with the IR spectrum of phosphate (Fig. 1) to be used for analytical application.
IR spectra of 50 mM phosphatase substrates: AMP, ADP, ATP, UTP, glucose-1-phosphate (G-1P), β-glycerophosphate (β-GP), p-nitrophenylphosphate (p-NPP), PPi and Pi in buffer A (100 mM Tris-HCl pH 8.0, 5 μM ZnCl2 and 5 mM MgCl2) recorded at 37°C.
The IR spectrum of Pi in buffer A revealed two bands at 1076 and 990 cm-1 (Fig. 1) that are assigned respectively to asymmetric and symmetric stretching vibrations of O-P-O, respectively [32]. The position of the phosphate bands is sensitive to their ionic environment as in the case of nucleotides [33] or phospholipids [34,35]. To illustrate the potential of the IR assay in assessing phosphatase activity in cells, we measured IR spectrum immediately (with 3 min delay) after mixing 50 mM substrate with osteoblast-like Saos-2 cells, (Fig. 2, dashed lines) and after 30 min of incubation (Fig. 2, full lines).
IR spectra of 50 mM substrate (one among the substrates: AMP, ADP, ATP, UTP, G-1P, β-GP, pNPP, PPi and Pi) in buffer A containing Saos-2 cells (6–15 mg of Saos-2-cell protein mL-1), recorded immediately after mixing the substrate with cells (dashed lines) and after 30 min (full lines) at 37°C. The bottom trace shows the spectrum of 50 mM Pi to indicate the positions of the two 1076–1080 and 990 cm-1 bands.
In all cases (with AMP, ADP, ATP, UTP, G-1P, β-GP), pNPP or PPi), the intensity of one or both Pi bands at 1076–1080 and 990 cm-1 increased, indicating the phosphatase activity in the whole cells (Fig. 2). It was clearly observed in the successive difference spectra (spectrum measured at the indicated time minus that measured immediately after mixing 50 mM substrate with Saos-2 cells) (Fig. 3).
Successive difference spectra of Saos-2 cells with 50 mM substrate (AMP, ADP, ATP, UTP, G-1P, β-GP, pNPP and PPi) in buffer A (spectrum measured after a given time minus that measured immediately after mixing the substrate with cells) at 37°C determined at 5, 10, 20 and 30 min. The negative intensities indicated the decline of substrate concentration while the positive intensities of the 1076–1080 and the 990 cm-1 bands indicated the appearance of Pi. The bottom trace shows the spectrum of 50 mM Pi to show the positions of the two 1076–1080 and 990 cm-1 bands.
Negative peaks indicated the disappearance of the substrate while positive peaks at 1076–1080 and 990 cm-1 illustrated the formation of Pi (Fig. 3). Hydrolysis of ATP, UTP and ADP in the Saos-2 cells produced Pi (positive 1088–1080-cm-1 and 990-cm-1 bands) and AMP (positive 977-cm-1 band) (Fig. 3). In the case of AMP hydrolysis, the Pi bands (located 1088–1080 cm-1 and 990 cm-1) overlapped with the AMP bands (located at 1088 cm-1 and 977 cm-1) rendering difficult to observe the Pi bands. We also observed hydrolysis of G-1P, β-GP and pNPP and PPi in Saos-2 cells indicating a broad phosphatase activity. Buffer A has the disadvantage of inducing cell aggregation after several hour incubation but its absorption in the 1200–1000-cm-1 region (Fig. 4a, dashed line) is lower than that of DMEM cellular medium (Fig. 4a, full line).
(a) IR spectrum of buffer A and IR spectrum of DMEM. (b) IR spectra of Saos-2 cells (12 mg of Saos-2-cell protein mL-1) with 50 mM PPi in buffer A recorded immediately after mixing the substrate with cells (dashed line) and after 30 min incubation at 37°C (full line). The spectrum of buffer A was deducted from the spectra of Saos-2 cells. (c) IR spectra of Saos-2 cells (28 mg of Saos-2-cell protein mL-1 with 50 mM PPi in DMEM recorded immediately after mixing the substrate with cells (dashed line) and after 30 min incubation at 37°C (full line). The spectrum of DMEM was deducted from the spectra of Saos-2-cells. (d) IR spectra of primary osteoblast cells (45 mg of cell protein mL-1) in buffer A with 50 mM PPi recorded immediately after mixing PPi with cells (dashed line) and after 30 min incubation at 37°C (full line). The spectrum of buffer A was deducted from the spectra of osteoblasts.
The feasibility to monitor the hydrolysis of PPi by Saos-2 cells in DMEM was verified. Typical IR spectra of 50 mM PPi with Saos-2 cells in buffer A (Fig. 4b) or in DMEM (Fig. 4c) immediately after mixing PPi with Saos-2 cells (full trace) and after 30 min incubation (dashed trace) indicated both the decrease of the 1100-cm-1 band of PPi and the increase of the 1076–1080-cm-1 band of Pi, confirming the PPi hydrolysis. Furthermore, the 1550-cm-1 protein band allowed us to determine directly protein concentration using the concentration absorption coefficient ε = 3.6 mg-1mL cm-1. Saos-2 osteoblast-like cells were selected due to their high TNAP activity, making it easier to monitor phosphatase activity. However they have different phenotypic properties in comparison with the corresponding healthy osteoblasts. Primary osteoblasts from mouse calvaria exhibited also PPi hydrolysis both in buffer A (Fig. 4d) and in DMEM but it was much lower than that of Saos-2 cells. This was confirmed qualitatively by the magnitude of the difference in IR spectra (spectrum measured after 30 min minus that measured immediately after mixing PPi with cells) recorded for Saos-2 cells in buffer A (Fig. 5a) and in DMEM medium (Fig. 5b) which were higher than that those of primary osteoblasts in buffer A (Fig. 5c) and in DMEM (Fig. 5d) respectively.
(a) Successive IR difference spectra of Saos-2 cells (12 mg of Saos-2-cell protein mL-1) in buffer A with 50 mM PPi at 37°C from 5 min to 30 min (spectrum recorded after the indicated time minus spectrum recorded immediately after mixing substrate with cells). (b) IR difference spectrum of Saos-2 cells (28 mg of cell protein mL-1) with 50 mM PPi in DMEM medium at 37°C (spectrum recorded after 30 min minus spectrum recorded immediately after mixing substrate with cells). (c) IR difference spectrum of primary osteoblast cells (45 mg of cell protein mL-1) with 50 mM PPi in buffer A at 37°C (spectrum recorded after 30 min minus spectrum recorded immediately after mixing substrate with cells). (d) IR difference spectrum of primary osteoblast cells (220 mg of cell protein mL-1) with 50 mM PPi in DMEM at 37°C. (spectrum recorded after 30 min minus spectrum recorded immediately after mixing substrate with cells).
Determination of specific activity of phosphatase in Saos-2 cells
The kinetic parameters are easily obtained from IR spectra. For example, the PPi hydrolysis by Saos-2 cells is followed by an increase of the 990-cm-1 band of Pi (Fig. 6a) and the concomitant decrease of the 1120–1100-cm-1 band of PPi (Fig. 6b).
(a) Absorption of PPi-band as a function of incubation time and of Saos-2 cell protein concentration (from 7.5 to 18 mg mL-1). (b) Absorption of PPi in 1120–1100-cm-1 region as a function of incubation time and of Saos-2 cell protein concentration. (c) Specific activity of PPi hydrolysis by Saos-2 cells at three concentrations from 7.5, 12 and 18 mg mL-1. One enzyme unit (1 U) is expressed as 1 nmol hydrolyzed PPi per min at 37°C. As expected, the specific activity values determined as function of protein concentration in cells were not significantly different from each other. (d) Determination of IC50 of levamisole by measuring inhibition of PPi hydrolysis by Saos-2 cells.
The absorbance changes of 1120–1100-cm-1 band of PPi (Fig. 6b) and the 990-cm-1 band of Pi (Fig. 6a) served to determine the PPi hydrolysis (Table 1).
As expected, increasing the amount of Saos-2 cells, from 7.5 mg mL-1, 12 mg mL-1 to 18 mg mL-1, as determined by the protein band, increased the PPi hydrolysis but the specific activity remained at the level of 102 ± 4 nmol min-1 mg-1 as expected (Fig. 6c and Table 1). There is not a statistically significant difference between the specific activities (P value is at least greater than 0.513). This compares well with the specific PPi hydrolysis of 130 nmol min-1 mg-1 in mammalian HeLa cells at pH 8.5 (36) as assayed by the modified method of Fiske and Subbarow. Quantitative determinations were also obtained for AMP, G-1P, β-GP, pNPP using both Pi bands at 990 and 1076–1080 cm-1 (Table 1). The substrate bands were also used to determine enzyme specific activity, as in the case of AMP (977 cm-1), pNPP (980 cm-1) and PPi (1107 cm-1) (Table 1). Specific activities determined either from Pi or from substrate-bands were identical within experimental errors except for G-1P and β-GP due to strong band overlapping. To check if the pyrophosphatase activity originates from TNAP-enriched cells, levamisole (a TNAP inhibitor) was added to the medium. At the concentration of 5 mM, levamisole almost completely inhibited the PPi hydrolysis by Saos-2 cells (Fig. 6d), suggesting that TNAP contributed mostly to the PPi hydrolysis of Saos-2 cells. Relative activity instead of specific activity was used to take into account of cell variability. 100% corresponded to the specific activity without the addition of inhibitor. An IC50 value of 1.16 ± 0.03 mM was obtained for the inhibition of phosphatase activity of levamisole which is comparable with the reported concentration of 1 mM levamisole that blocked calcification in cultures of aortas from uremic rats [37].
Determination of specific activity of phosphatase in matrix vesicles
Matrix vesicles (MVs) extracted from growth plates and epiphyseal cartilage of 17-day-chicken embryos were also assayed for PPi hydrolysis since they have 10–40 fold higher TNAP specific activity than cells. MV size is around 100–400 nm diameter as determined by electron microscope [38]. Typical example of a series of IR spectra during PPi hydrolysis of MVs in Buffer A supplemented with 50 mM PPi monitored at 37°C are shown in Fig. 7a.
(a) Kinetic recording of 50 mM PPi hydrolysis by 2 mg MV protein mL-1 in buffer A at 37°C. Successive infrared spectra were measured at the indicated times. (b) Difference IR spectra of MVs with PPi (spectrum recorded at the indicated time minus that recorded immediately). Significant variation in the intensity of absorption bands of PPi located at 1120–1100 cm-1 as well as other variations attributed to Pi at 1076–1080 cm-1 and 990 cm-1 were observed. (c) Expected IR difference spectrum of product and substrate (2xPi minus PPi) (dashed line). IR difference spectrum of the hydrolysis of 50 mM PPi by 2.5 mg MV protein mL-1 in buffer A (spectrum recorded at 60 min minus spectrum recorded immediately) (Full line) d) Sensitivity of the infrared assay to determine the hydrolysis of 50 mM PPi by 2.5 mg MV protein mL-1 (full line) and by 0.2 mg MV protein mL-1 (dashed line) as shown by their difference spectrum respectively (spectrum of MVs with 50 mM PPi recorded at 30 min minus spectrum recorded immediately).
The intensity decrease of the 1120–1100 cm-1 band related to the disappearance of PPi is correlated with the increase in the 1076–1080 and 990 cm-1 bands (Fig. 7a), indicating a hydrolysis of PPi by MVs and an appearance of Pi. It is better seen in the difference infrared spectra, e.g. from the IR spectrum of MVs recorded at the indicated time minus that recorded immediately (Fig. 7b), which were similar with difference spectra of Saos-2 cells with PPi (Fig. 3) and also with those of alkaline phosphatase with PPi (data not shown). The calculated IR difference, i.e. spectrum of Pi minus spectrum of PPi (Fig. 7c, dashed line) is almost identical to the IR difference spectrum of MVs with PPi (spectrum recorded after 60 min minus the spectrum recorded immediately) (Fig. 7c, full line). The IR changes produced by PPi hydrolysis by MVs corresponded to the calculated decrease of one PPi and to the formation of two Pi. We estimated the sensitivity of the IR assay during 30-min incubation to be about 0.2 mg mL-1 MV protein. At 0.2 mg mL-1 MV protein, only faint bands not much more intensive than the noise signal are detected (Fig. 7d, dashed line), while at 2.5 mg mL-1 MV protein, the IR bands indicating disappearance of PPi and appearance of Pi are well resolved (Fig. 7d, full line). Activity measurements were determined by measuring absorbance changes of the absorbance changes of PPi band located at 1107 cm-1 using ε = 2158 ± 211 M-1 cm-1 (Fig. 8a) as well as with two Pi bands located at 990 cm-1 (Fig. 8b) and 1076 cm-1 (Fig. 8c), using ε = 443 ± 50 M-1 cm-1 and ε = 1215 ± 131 M-1 cm-1, respectively. As a result we determined an apparent hydrolytic activity of MVs towards PPi of 1132 ± 370 nmol min-1 mg-1.
(a) Absorption changes of PPi band at 1107 cm-1; (b) Absorption changes of Pi peak at 990 cm-1; (c) Absorption changes of Pi band at 1076 cm-1 during PPi hydrolysis by 2 mg mL-1 MVs in buffer A at 37°C in the absence (◆) or presence (∎) of 5 mM levamisole.
For comparison, the TNAP activity of MVs determined at pH 10.4 using the pNPP as a substrate, amounted to 30 000 ± 10 000 nmol min-1 mg-1. This is consistent with the reported values for alkaline phosphatase extracted from HeLa cells, having a PPi hydrolytic activity at pH 8.5 about 26 to 30 times smaller than the pNPP hydrolytic activity at pH 10.5 [36]. To test if the hydrolysis of PPi is specifically associated to TNAP, we incubated the reactive medium containing MVs and 50 mM PPi with 5 mM levamisole, a TNAP specific inhibitor. Addition of levamisole induced a smaller slope in the absorbance changes at 1107 cm-1 (Fig. 8a), at 990 cm-1 (Fig. 8b) and at 1076 cm-1 (Fig. 8c) as compared with the control sample without levamisole (Fig. 8). We observed a significant inhibition of PPi hydrolysis in the presence of 5 mM levamisole from 1132 ± 370 nmol min-1 mg-1 (without levamisole) to 343 ± 112 nmol min-1 mg-1 (with 5 mM Levamisole) confirming that TNAP is to a large extent responsible for PPi hydrolysis. Since the levamisole could not block completely the phosphatase activity, there is the possibility that other phosphatases such as NPP1 can catalyze the phosphatase activity. Indeed, NPP1, which usually hydrolyses phosphodiester bond can also hydrolyze phosphomonoester bond at a lesser extend [39].
Conclusion
It has been recognized earlier that IR spectroscopy has considerable potential as a tool in diagnostics since it may be used to assess biochemical changes of cells exposed to various inhibitors [20–28]. Here we demonstrated the ability of IR spectroscopy to directly determine in situ a phosphatase activity in osteoblasts using natural substrates without any labeling. We showed the ability of IR spectroscopy to directly determine simultaneously protein concentration and the phosphatase activity in cultured osteoblasts as well as in matrix vesicles using physiological substrates such as AMP, ADP, ATP, UTP, and PPi. The method has been validated for osteoblasts (Saos-2 cells and primary osteoblasts) and chondrocyte-derived matrix vesicles which are all TNAP enriched. This approach could be extended to determine alkaline phosphatase activity as well as any type of phosphatase activity in other cells. It may serve as a metabolomic tool to determine an overall phosphatase activity in a cell which may involve several enzymes.
Author Contributions
Conceived and designed the experiments: GB LDD RB S. Mebarek ZR. Performed the experiments: GB NK LDD SA S. Meena S. Mebarek RB ZR. Analyzed the data: DM LDD RB S. Mebarek SP YW. Contributed reagents/materials/analysis tools: GB LDD NK SA SM S. Mebarek ZR. Wrote the paper: DM LDD RB S. Mebarek YW ZR.
References
- 1. Buchet R, Millán JL, Magne D. Multisystemic functions of alkaline phosphatases. Methods Mol Biol. 2013;1053: 27–51. pmid:23860646
- 2. Dahl R, Sergienko EA, Su Y, Mostofi YS, Yang L, Simao AM, et al. Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). J Med Chem. 2009;52: 6919–6925. pmid:19821572
- 3. Sergienko EA, Millán JL. High-throughput screening of tissue-nonspecific alkaline phosphatase for identification of effectors with diverse modes of action. Nat Protoc. 2010;8: 1431–1439. pmid:20671726
- 4. Bleicher KH, Böhm HJ, Müller K, Alanine AI. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov. 2003;2: 369–378. pmid:12750740
- 5. Barth A, Zscherp CQ. What vibrations tell us about proteins. Rev Biophys. 2002;35: 369–430 pmid:12621861
- 6. Naumann D, Helm D, Labischinski H. Microbiological characterizations by FT-IR spectroscopy. Nature. 1991;351: 81–82. pmid:1902911
- 7. Bosch A, Prieto C, Serra DO, Martina P, Stämmbler M, Naumann D, et al. Type-IV pili spectroscopic markers: applications in the quantification of piliation levels in Moraxella bovis cells by a FT-IR ANN-based model. J Biophotonics. 2010;8–9: 522–533.
- 8. Helm D, Labischinski H, Schallehn G, Naumann DJ. Classification and identification of bacteria by Fourier transform infrared spectroscopy. J Gen Microbiol. 1991;137: 69–79. pmid:1710644
- 9. Rebuffo C, Schmitt J, Wenning M, von Stetten F, Scherer S. Reliable and rapid identification of listeria monocytogenes and listeria species by artificial neural network- based Fourier transform infrared spectroscopy. Appl Environ Microbiol. 2006;72: 994–1000. pmid:16461640
- 10. Bosch A, Minan A, Vescina C, Schmitt J, Degrossi J, Gatti B, et al. Fourier transform infrared spectroscopy for rapid Identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients. J Clin Microbiol. 2008;46: 2535–2546. pmid:18550747
- 11. Harvey TJ, Henderson A, Gazi E, Clarke NW, Brown M, Faria EC, et al. Discrimination of prostate cancer cells by reflection mode FTIR photoacoustic spectroscopy. Analyst. 2007;132: 292–295. pmid:17554407
- 12. Bhargava R. Towards a practical Fourier transform infrared chemical imaging protocol for cancer histopathology. Anal Bioanal Chem. 2007;389: 1155–1169. pmid:17786414
- 13. Holton SE, Walsh MJ, Bhargava R. Subcellular localization of early biochemical transformations in cancer-activated fibroblasts using infrared spectroscopic imaging. Analyst 2011;136: 2953–2958. pmid:21647505
- 14. Benard A, Desmedt C, Smolina M, Szternfeld P, Verdonck M, Rouas G, et al. Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment. Analyst. 2014;139: 1044–1056. pmid:24418921
- 15. Derenne A, Vandersleyen O, Goormaghtigh E. Lipid quantification method using FTIR spectroscopy applied on cancer cell extracts. Biochim Biophys Acta. 2014;1841: 1200–1209. pmid:24157469
- 16. Kumar S, Desmedt C, Larsimont D, Sotiriou C, Goormaghtigh E. Change in the microenvironment of breast cancer studied by FTIR imaging. Analyst. 2013;138: 4070–4075. pmid:23675579
- 17. Holton SE, Bergamaschi A, Katzenellenbogen BS, Bhargava R. Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer. PLOS One. 2014;9(5): e96878. pmid:24816718
- 18. Diem M, Romeo M, Boydston-White S, Miljkovic M, Matthäus C. A decade of vibrational micro-spectroscopy of human cells and tissue (1994–2004). Analyst. 2004;129: 880–885. pmid:15457314
- 19. Pereira TM, Zezell DM, Bird B, Miljković M, Diem M. The characterization of normal thyroid tissue by micro-FTIR spectroscopy. Analyst. 2013;138: 7094–7100. pmid:24137615
- 20. Krishna CM, Kegelaerl G, Adt I, Rubin S, Kartha VB, Manfait M, et al. Combined Fourier transform infrared and Raman spectroscopic identification approach for identification of multidrug resistance phenotype in cancer cell lines. Biopolymers. 2006;82: 462–470. pmid:16493658
- 21. Matthäus C, Bird B, Miljkovic M, Chernenko T, Romeo M, Diem M. Infrared and Raman Microscopy in Cell Biology Methods Cell Biol. 2008;89: 275–308. pmid:19118679
- 22. Zwielly A, Gopas J, Brkic G, Mordechai S. Discrimination between drug-resistant and non-resistant human melanoma cell lines by FTIR spectroscopy. Analyst 2009;134: 294–300. pmid:19173052
- 23. Gasper R, Dewelle J, Kiss R, Mijatovic T, Goormaghtigh E. IR spectroscopy as a new tool for evidencing antitumor drug signatures. Biochim Biophys Acta. 2009;1788: 1263–1270. pmid:19250921
- 24. Diem M, Papamarkakis K, Schubert J, Bird B, Romeo MJ, Miljković M. The infrared spectral signatures of disease: extracting the distinguishing spectral features between normal and diseased states. Appl Spectrosc. 2009;63: 307A–318A. pmid:19891826
- 25. Vileno B, Jeney S, Sienkiewicz A, Marcoux P, Miller L, Forro L. Evidence of lipid proxydation and protein phosphorylation in cells upon oxydative stress photo-generated by fullerols. Biophys Chem. 2010;152: 164–169. pmid:20970241
- 26. Gasper R, Mijatovic T, Bénard A, Derenne A, Kiss R, Goormaghtigh E. FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line. Biochim Biophys Acta. 2010;1802: 1087–1094. pmid:20656024
- 27. Flower K, Khalifa I, Bassan P, Démoulin D, Jackson E, Lockyer N, et al. Synchotron FTIR analysis of drug treated ovarian A2780 cells: an ability to differenciate cell response to different drugs? Analyst. 2010;136: 498–507. pmid:21088767
- 28. Gasper R, Vandenbussche G, Goormaghtigh E. Ouabin induced modifications of prostate cancer cell lipidome investigated with mass spectrometry and FTIR spectroscopy. Biochim Biophys Acta. 2011;1808: 597–560. pmid:21144819
- 29. Lendl B, Krieg P, Kellner R. Determination of alkaline phosphatase activity in human sera by mid-FTIR spectroscopy. Fresenius J Anal Chem. 1998;360: 717–720.
- 30. Wu LN, Yoshimori T, Genge BR, Sauer GR, Kirsch T, Ishikawa Y, et al. Characterization of the nucleational core complex responsible for mineral induction by growth plate cartilage matrix vesicles. J Biol Chem. 1993;268: 25084–25094. pmid:8227072
- 31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248–254. pmid:942051
- 32. Tsuboi M. Vibrational spectra of phosphite and hypophosphite anions and the 24 characteristic frequencies of PO3—and PO2—groups. J Am Chem Soc. 1957;79: 1351–1354.
- 33. Wang JW, Xiao DG, Deng H, Webb MR, Callender R. Raman difference studies of GDP and GTP binding to c-Harvey ras. Biochemistry. 1998;37: 11106–11116. pmid:9693007
- 34. Yamamoto I, Konto A, Handa T, Miyajima K. Regulation of phospholipase D activity by neutral lipids in egg-yolk phosphatidylcholine small unilamellar vesicles and by calcium ion in aqueous medium. Biochim Biophys Acta. 1995;1233: 21–6. pmid:7833345
- 35. Do le D, Buchet R, Pikula S, Abousalham A, Mebarek S. Direct determination of phospholipase D activity by infrared spectroscopy. Anal Biochem. 2012;430: 32–8. pmid:22842398
- 36. Cox RP, Gilbert P Jr, Griffin MJ. Alkaline Inorganic Pyrophosphatase Activity of Mammalian-Cell Alkaline Phosphatase. Biochem J. 1967;105: 155–161. pmid:4964763
- 37. Lomashvili KA, Garg P, Narisawa S, Millan JL, O’Neill WC. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int. 2008;73: 1024–1030. pmid:18288101
- 38. Thouverey C, Malinowska A, Balcerzak M, Strzelecka-Kiliszek A, Buchet R, Dadlez M, et al. Proteomic characterization of biogenesis and functions of matrix vesicles released from mineralizing human osteoblast-like cells. Journal of Proteomics. 2011;74: 1123–1134. pmid:21515422
- 39. Zalatan JG, Fenn TD, Brunger AT, Herschlag D. Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: implications for mechanism and evolution. Biochemistry. 2006;45: 9788–9803. pmid:16893180